You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

DEXEDRINE SPANSULE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dexedrine Spansule patents expire, and what generic alternatives are available?

Dexedrine Spansule is a drug marketed by Impax Labs Inc and is included in one NDA.

The generic ingredient in DEXEDRINE SPANSULE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dexedrine Spansule

A generic version of DEXEDRINE SPANSULE was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEXEDRINE SPANSULE?
  • What are the global sales for DEXEDRINE SPANSULE?
  • What is Average Wholesale Price for DEXEDRINE SPANSULE?
Summary for DEXEDRINE SPANSULE
Drug patent expirations by year for DEXEDRINE SPANSULE
Drug Prices for DEXEDRINE SPANSULE

See drug prices for DEXEDRINE SPANSULE

Pharmacology for DEXEDRINE SPANSULE

US Patents and Regulatory Information for DEXEDRINE SPANSULE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc DEXEDRINE SPANSULE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 017078-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc DEXEDRINE SPANSULE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 017078-002 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc DEXEDRINE SPANSULE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 017078-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.